Last reviewed 2026-04-19 · How we verify

Hormone receptor positive malignant neoplasm of breast

27 treatments

Approved treatments

Xyosted (Autoinjector) · Endo
Androgel · Besins Hlthcare
Zoladex · Tersera
ZOLADEX inhibits pituitary gonadotropin secretion, leading to regression or inhibition of hormonally sensitive tumors.
Zoladex · Tersera
Zoladex works by mimicking the body's natural hormone to reduce testosterone production.
Testosterone Cypionate · Azurity
Aromasin · Pfizer
Afinitor · Novartis
Afinitor works by blocking the mTOR protein, which is involved in cell growth and division.
PD-0332991 · Pfizer Inc.
PD-0332991, 125mg, 3 cycles
Afinitor · Central European Society for Anticancer Drug Research
Testosteron · Gulhane School of Medicine
Kisqali · Novartis
Kisqali works by blocking a protein called cyclin-dependent kinase 4, which helps cancer cells grow and divide.
Anamidol
Anamidol binds to androgen receptors in the body, triggering a cascade of downstream effects that promote muscle growth and development.
Fluotestin
Verzenio · Eli Lilly
Abemaciclib inhibits CDK4 and CDK6, blocking Rb phosphorylation and G1/S cell cycle progression.
Kisqali · Novartis
Ribociclib inhibits CDK4/6 kinases to arrest G1 cell cycle phase; letrozole inhibits aromatase to reduce estrogen biosynthesis.
Arimidex · AstraZeneca
Anastrozole selectively inhibits aromatase enzyme, suppressing estrogen biosynthesis in postmenopausal breast cancer.
Femara · M.D. Anderson Cancer Center
Femara · Novartis AG
Letrozole reduces estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogens.
Testosterone cypionate (200mg/3ml) · Leticia Maria Defendi Barboza Marson
Aromasin · Pfizer
Aromasin works by blocking the aromatase enzyme, which is responsible for converting androgens into estrogens.
Megace · Bristol-Myers Squibb
Testred · Bausch Health
Ibrance · Pfizer
Palbociclib inhibits CDK4/6 to block G1/S cell cycle progression in ER-positive breast cancer.
Anastrazole · AstraZeneca
Zoladex · University of Michigan Rogel Cancer Center
megestrol · National Center for Research Resources (NCRR)
Arimidex · University of Colorado, Denver

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Hormone receptor positive malignant neoplasm of breast patent landscape — cliff calendar, originator estates, attackable patents
Hormone receptor positive malignant neoplasm of breast treatment landscape brief
Hormone receptor positive malignant neoplasm of breast treatment updates RSS

Frequently asked questions about Hormone receptor positive malignant neoplasm of breast

What drugs treat Hormone receptor positive malignant neoplasm of breast?

Tracked treatments include Xyosted (Autoinjector), Androgel, Zoladex, Testosterone Cypionate, Aromasin, Afinitor, PD-0332991, Testosteron.

What is the treatment for Hormone receptor positive malignant neoplasm of breast?

Standard treatment for Hormone receptor positive malignant neoplasm of breast includes Xyosted (Autoinjector), Androgel, Zoladex, Testosterone Cypionate, Aromasin. See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: Hormone receptor positive malignant neoplasm of breast patent cliff · Hormone receptor positive malignant neoplasm of breast CI report
Treatment: Xyosted (Autoinjector) · Endo
Treatment: Androgel · Besins Hlthcare
Treatment: Zoladex · Tersera
Treatment: Zoladex · Tersera
Treatment: Testosterone Cypionate · Azurity
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing